Click here to view our 2021-2022 Approved Grants

Congratulations to the most recent Australian Vision Research Grant Recipients!

Important reminders for applicants:

  • Each investigator may be included on one ORIA submission each year only.
  • At least one investigator must be a current RANZCO and ORIA member.
  • When applying only the chief investigator may submit the application
  • Each registered account can only submit one application.
  • Each submission page must be saved prior to final submission
  • Once the application is submitted it cannot be edited

Applications closed May 24th 2022

Australian Vision Research (AVR) invites applications for research funding in 2022-2023. Grants will be available to ophthalmologists, trainee ophthalmologists or for work being done in University Departments (or equivalent) of Ophthalmology or Ophthalmic Research Institutes. At least one member of the investigator team must be a Fellow of the Royal Australian and New Zealand College of Ophthalmology and a member of the AVR. If unsure of eligibility, please contact the AVR (

If the investigator is applying from overseas, the majority of the project work should be conducted in Australia with both the investigator and the project being administered through an Australian institution.

In 2021, the board of AVR approved $539,258 for allocation towards 11 projects for 2022.  The amount of money available each year varies, currently the AVR will consider funding individual grants for up to $50,000 for a period of one year.

The AVR encourages pilot projects that will produce data to enable subsequent submissions to other bodies for larger grants as well as projects which have clearly defined aims that can be achieved in the one year of funding. Again, grants are available for a period of one year.

Each grant is peer reviewed by experts in the field before a final decision is made by the AVR’s Research Advisory Committee. The AVR has procedures to manage conflicts of interest. The decision by the Research Advisory Committee is final.

Successful project funding will be announced at the Annual General Meeting of the AVR to be held in late 2022.

Funding commences from January 2023 only after acceptance of the AVR’s award requests and the provision of ethics approval. Grant recipient funds are expected to be expended within a year from commencement.

We are continuing with the ‘Priming Grant’ Scheme this year. The Priming Grant has been established to encourage applications from RANZCO Fellows and AVR members who are in the early stages of their clinical-research career. To be eligible for a ‘Priming Grant’ the first named principal investigator (i.e., CIA) must be within the first 5 years of obtaining their RANZCO Fellowship or higher degree (after taking into consideration career disruption), and a member of the AVR. Other researchers may be named on the investigator team; however, each investigator may be included on only one AVR submission each year. Priming Grants will be reviewed, considered, and scored in accordance with all other proposals. Provided eligible grants are submitted, at least one proposal will be funded in this category each year. More than one priming grant may be funded each year.

Researchers interested in applying through the Priming Grant scheme may also discuss their proposal with a member of the AVR Research Advisory Committee, prior to their submission. This discussion provides the applicant the opportunity to seek direction about their research idea, and the formulation of their proposal. If you are interested in receiving this informal, and non-binding pre-submission feedback, you must contact us via email: at least 21 days prior to the submission deadline with the heading Grant Pre-submission.

Successful investigators are required to provide a half page final report on the project, including a lay description by 30 June 2024. The report should include details of any publications arising from this research with links to the actual publication. A final budget indicating how funds were expended shall also form part of your report (Failure to do this may have a negative bearing on future applications). It is the applicants’ responsibility to ensure provision of this documentation. Investigators will also be asked to provide updates on results and funding arising from the research at intervals after the one-year period. These updates will be used to promote AVR through various media and also to assess and demonstrate impact of grant funding.

In submitting an application for funding, it should be expected that the title or other relevant information may be submitted to other bodies associated with the AVR, and participation in publicity activities e.g., photos, interviews, updates for publication in newsletters may be requested.

Important reminders for applicants:

  • Applicants must register an account via the AVR online portal and applications must be submitted via the AVR online portal
  • Each investigator may be included on one AVR submission each year only.
  • At least one investigator must be a current RANZCO and AVR member.
  • When applying only the chief investigator may submit the application
  • Applicants can only submit one application.
  • Each submission page must be saved prior to final submission
  • Once the application is submitted it cannot be edited
  • All responses to the below must be numbered and answered appropriately in your application.


Applications will only be accepted by submitting a proposal by the due time and date and in the correct format as indicated below.

Attachments should be saved as PDF documents only including CV’s and any supporting material. Times New Roman Size 12-point font should be used throughout including for references and CVs.

The proposal should be uploaded to the AVR Grants Portal.

Please construct your proposal by addressing the following points in consecutive order and numbering your responses.

All points below must be numbered correctly and answered accurately in your application, failure to do so will lead to the application being returned.

No applications will be accepted after 11:59 pm, AEST time on Tuesday 24th May 2022. Any applications received after this date and time, in an incomplete format or that do not comply with the application guidelines will not be considered and will be returned.

Other information and expectations of the grant recipients

Research Integrity

We’re committed to responsible research

The Ophthalmic Research Institute of Australia trading as Australian Vision Research is committed to complying with the highest standards of ethics and research integrity.

The National Health and Medical Research Council (NHMRC) and Aboriginal Health & Medical Research Council (AH&MRC) statement and guidelines outline what is expected from everyone engaged in research.

Further information can be found at:

By submitting your application, you agree to abide by these standards.

Ethics Approval

  • All Projects involving experimentation on humans or animals require approval of the Ethics Committee of the appropriate institution.
  • A signed completed Institutional Ethics Committee approval form must be submitted before any funds will be distributed to successful recipients.

AVR Marketing and Branding

  • Successful applicants are required to acknowledge AVR on any publication, presentation by using the AVR Logo or mentioning AVR project funding as appropriate.
  • In order to support the AVR’s presence online and improve the investigators’ Altmetric Score (; investigators and their institutions are required to acknowledge the AVR in when marketing their research and subsequent research.